Clinical Trial Update: Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and exploratory efficacy results for NEUROSTEM in Alzheimer's disease across Phase 1 and Phase 2, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NEUROSTEM

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED